FOSTER CITY, Calif. & SAN DIEGO--(BUSINESS WIRE)--Entelos, Inc., a simulation and modeling company focused on human health, and RegeneMed, Inc., a tissue-based drug discovery and regenerative medicine company, announced today the release of iToxFX™.
FOSTER CITY, Calif. & SAN DIEGO--(BUSINESS WIRE)--Entelos, Inc., a simulation and modeling company focused on human health, and RegeneMed, Inc., a tissue-based drug discovery and regenerative medicine company, announced today the release of iToxFX™.
